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ABSTRACT
Investigation of the biosynthetic process of indigoidine
By
Yi Chen, Master of Science
Utah State University, 2019
Major professor: Jixun Zhan
Department: Biological Engineering
Indigoidine (5,5′-diamino-4,4′-dihydroxy-3,3′-diazadiphenoquinone-(2,2′))
is a natural product synthesized by a non-ribosomal peptide synthetase (NRPS). It
features a unique bright blue color similar to industrial dye indigo. It has antioxidant
and antimicrobial activities, and the responsible gene can be used as a reporter
system for gene expression. Several bacterial strains have the potential to produce
indigoidine. However, some hosts have silent indigoidine biosynthetic genes, while
others have very limited production of indigoidine. Heterologous expression of the
responsible synthetase gene will significantly benefit its large-scale production and
industrial applications.
Previously, we cloned a putative indigoidine synthetase gene (Sc-indC)
from Streptomyces chromofuscus ATCC 49982. Heterologous expression of the ScindC in Escherichia coli (E. coli) achieved indigoidine production of 20 g/L under
optimized conditions. Exploring the biosynthetic mechanism of indigoidine will
potentially open new doors for further improvement of the production of this
natural dye.

I

As NRPSs, most indigoidine synthetases were predicted to have four
functional domains: adenylation domain (A), thiolation (T), thioesterase (TE), and
a special oxidation (Ox) integrated into the A domain, except that Sc-IndC has an
additional C-terminal 4-oxalocrotonate tautomersase (4-OT) domain. It was
proposed that the A domain activates the substrate L-glutamine (L-Gln), and
transfers it to the T domain, where the TE domain catalyzes the cyclization to
produce the intermediate pyro-glutamine (pyro-Gln). The intermediate compound
was then released from T domain as a free molecule, and subsequently oxidized by
the Ox domain, yielding 5-amino-3H-pyridine-2,6-one, which is finally dimerized
to produce indigoidine. However, the proposed biosynthetic mechanism has not
been confirmed and the sequence of the oxidation and cyclization still remains
unknown.
Although Sc-IndC has been reconstituted in E. coli BAP1 with higher
activity, we found it had relatively lower in vitro activity compared to BpsA. So,
my study was mainly focused on the biosynthetic mechanism of indigoidine by
BpsA and Sc-IndC. The corresponding genes bpsA and Sc-indC were derived from
two different bacteria.
Firstly, I cloned and heterologously expressed bpsA, Sc-indC, and their gene
fragments in E. coli BAP1, and then purified the recombinant proteins. Then, I
chemically synthesized L-glutamine-SNAC, which mimics the thiolated glutamine
in the biosynthetic process. Finally, I optimized the in vitro enzyme assay
conditions to test the enzymatic activity of the purified intact enzymes and domains
on the substrate L-glutamine, and the intermediates L-glutamine-SNAC and 3-
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aminopiperidine-2,6-dione (pyro-Gln). The products were analyzed by LC-MS to
reveal the biosynthetic process of indigoidine by BpsA and Sc-IndC. My results
showed that in the presence of ATP, BpsA can convert substrate L-glutamine, the
intermediates L-glutamine-SNAC and 3-aminopiperidine-2,6-dione to indigoidine.
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PUBLIC ABSTRACT
Investigation of the biosynthetic process of indigoidine
By
Yi Chen, Master of Science
Utah State University, 2019
Major professor: Jixun Zhan
Department: Biological Engineering
Indigoidine is a natural blue dye with antioxidant and antimicrobial
activities. It has also been used as an indicator for gene expression based on its
distinctive blue color. Similar to the industry blue dye indigo, indigoidine has a
promising potential to be applied in industry as a blue dye. However, the
indigoidine production level in the original microorganisms was very low.
Heterologous expression of the responsible synthetase gene in Escherichia coli can
facilitate the fast and large-scale production of indigoidine. Also, a good
understating of the working mechanism of the synthetase is favorable for the
industrial application.
In our previous study, a putative indigoidine synthetase gene (Sc-indC) has
been heterologously expressed in E. coli, and 20 g/L of indigoidine was produced
under optimized culture conditions. To further improve the production, we intended
to explore the indigoidine biosynthetic process by studying the working mechanism
of two indigoidine synthetases BpsA and Sc-IndC from two different bacteria.
Both BpsA and Sc-IndC were predicted to have similar domain architecture
that consists of an adenylation domain (A) with an embedded oxidation (Ox)
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domain, thiolation (T) domain, and thioesterase (TE) domain, except that Sc-IndC
has an additional C-terminal. To explore the enzymatic mechanism, I dissected the
gene between domains to get A-Ox-T/TE and A-Ox/T-TE, and co-expressed the
dissected fragments to find out whether they can work in the combination of pieces
as the intact enzymes do. On the other hand, I separately expressed the domains in
E. coli BAP1 and purified the resulting proteins, and tested the in vitro activities on
precursors individually or in different combinations. My results showed that the
intact enzymes can convert glutamine, glutamine-SNAC and pyor-Gln to
indigoidine in the presence of ATP. However, none of the dissected enzymes
showed the ability to form the blue dye in vitro or in vivo.
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CHAPTER I INTRODUCTION
1.1 Background
Introduction of indigo.
Indigo (indigotin, or 2,2'-Bis (2,3-dihydro-3-oxoindlyliden) features
distinctive bright blue color and has been broadly used for textile dyeing, printing,
food, and cosmetic applications 1. Since the 19th century, the worldwide demand
of blue jeans and denim cloth has been dramatically increased, accordingly the
production of indigo also intensely amplified 1b, 2. In 2011, 50,000 tons of indigo
was produced, of which up to 95% was applied in the dying of denim cloth 3.
Originally indigo was a rare natural dye. It was extracted from the leaves
of the plant genus Indigofera, specifically Indigofera tinctoria (or I. sumatrana),
which was mainly distributed in tropics, and predominantly in India1a, 1b, 4. People
who resided in less-warm areas, such as China, Japan, and Europe, also
alternatively extracted blue dye from native plants such as Strobilanthes cusiaw,
Persicaria tinctoria, Polygonum tinctorum, and Isatis tinctoria; another optional
source was the sea snail mollusk 1a, 1b, 4. However, the production of these bluedyes were of low concentration and purity, and easily tinged by other dye. So the
true indigo production was mainly originated from I. tinctoria, which was very
limited and rare. Hence people traded it as a luxury product and referred it as blue
gold 1b. Though later broad plantation brought relatively higher production, the
labor work was arduous and the production was highly environment-dependent.
The supply was still far less than the growing demand. For centuries, the plant–
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derived indigo was the only source of this blue dye. Figure 1 shows the pathway
of indigo in plant.

Figure 1 Chemical transformations occurred in the processing of the leaves in
dyeing with indigo 1b.
In the 1860s, chemists started to develop strategies to chemically
synthesize this compound. In 1870, the German chemist Adolf von Baeyer firstly
synthesized indigo from isatin. Later on he developed several other methods, but
all were in laboratory scale 5. To achieve the industrious production, Heumann
developed a strategy to heat the precursor N-(2-carboxyphenyl)glycine with
sodium hydroxide, and subsequently decarboxylated the resulting product to form
indoxyl, which was immediately oxidized as indigo dye in air. In the 1990s,
Johannes Pfleger realized the commercial production in large scale. They
produced the single unit indoxyl in one step through N-phenylglycine under harsh
base condition1b, 6. Since then, almost all of the indigo dye has been produced by
chemical synthesis 7. Nowadays, thousands of tons of indigo is produced
anniversary. However, mass chemical production unenviably brings serious
environmental pollution and material waste.
Microbial production of indigo could be an eco-friendly and high-efficient
strategy. It has been reported that microorganisms also produced indigo. In recent
years, biosynthetic pathway has been developed in E. coli to “naturally” produce
2

indigo from indole 8. However, the production has been in small scale and merely
satisfies the huge industrial demand.

Figure 2 Chemical synthesis of indigo based on Heumann‐Pfleger process.

Figure 3 Transformation of indigo in the dyeing process.
Indigo has good solubility in DMSO, but is less soluble in water and other
organic solvents, since it’s easy for this molecule to form intra- and
intermolecular hydrogen bond. A suppression on the formation of intramolecular
hydrogen bond might help with the solubility. During the dyeing process with
indigo, the low solubility makes the dyeing challenging. Usually reductant agent
is required to convert indigo into a soluble form, which is leuco-indigo, also
known as indigo white. The soluble indigo white physically attaches to the fabric,
and returns to indigo after being oxidized in the air, turning the fabric from
yellow-green to blue 9. Dying pigment has been a big problem of the water
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pollution, and the tough reducing condition of the dying with indigo make it more
hazardous.

Figure 4 Chemical structures for indigo and its colorant derivatives.
The chemical structure of indigo features a planar conjugation system of
adjacent double bonds, which contributes to its distinctive blue color (λmax = 613
nm). The modification of indigo molecule provides many different derivative
colorants, such as indigo carmine, thioindigo, tyrian purple (6,6'-dibromoindigo.
6-bromoindigo), and ciba blue (5,7,5′,7′-tetrabromoindigo). Indigo carmine is the
salt form of chemically synthesized indigo. It was listed as one of the rare blue
colorant, FD&C Blue No. 2, applied in food and cosmetic industry10.
Introduction of indigoidine.
Indigoidine (5,5′-diamino-4,4′-dihydroxy-3,3′-diazadiphenoquinone(2,2′)) is a non-ribosomal peptide synthetase (NRPS)-associated natural product.
It features a distinct blue color similar to indigo, thus named as indigodine. While
chemically synthesized indigo might bring health risks, the naturally produced
indigoidine has an advantage of antioxidant and anti-microbial activities 11 12.
Owing to the highly oxidized and conjugated system in the chemical structure,
indigoidine acts as scavenger for free radicals, hence is less stable in liquid,
especially at high temperature, which makes it degradable and less-threatening to
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the water system. These properties make indigoidine a promising excellent
substitution of indigo as blue dye.
Due to its bright blue color, the responsible indigoidine synthetase gene
has been introduced to both E. coli and mammalian cells to construct reporter
system, which has been used as a visual indicator to high-throughput screen gene
expression. This was the first report that NRP could be produced by engineered
mammallian cells 13. The indigoidine synthetase BpsA has also been developed as
a reporter to screen PPTase and PPTase inhibitors 14, as well as PPTase-associated
natural product biosynthetic genes 15.
Previous studies showed that the indigoidine synthetase were present in
different strains (Table 1). However, this gene was silent in some of these strains,
while other bacteria had very limited production of indigoidine. Through
regulatory gene manipulation and heterologous expression, activation and
enhancement of indigoidine production can be achieved. To activate the
indigoidine NRPS, a 4’-phosphopantetheinyl transferase (PPTase) is required,
which transforms the indigoidine synthetase to the holo form by adding the
phosphopantetheinyl group from coenzyme A (CoA) to the T domain 13 16. It was
proved that the disruption of farR2 gene could lead to delayed production of
indigoidine in Streptomyces lavendulae FRI-5 17, and the disruption of either pecS
or pecM in Streptomyces lavendulae gene cluster could repress the indigoidine
production 11 18. By replacing the promotor of ORF with strong constitutive rpsM
promoter, the silent Sc-indC gene in Photorhabdus luminescens was successfully
activated to produce the blue pigment 16.
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The indigoidine synthetase BpsA contains one single module, which is
predicted to consist of an adenylation (A) domain, thiolation (T) domain,
thioesterase (TE) domain, and a special oxidation (Ox) domain integrated in the A
domain. Sc-IndC has the same domain organization except that it has an
additional C-terminal 4-oxalocrotonate tautomersase (4-OT) domain. The native
substrate L-glutamine (L-Gln) is activated by the A domain as amino acyl
adenylates (acyl-adenylated L-Gln), and transferred to the activated T domain,
where it is hydrolyzed and cyclized by the TE domain to form and release the
intermediate 5-aminopiperidine-2,6-dione. The single molecule is further oxidized
by the Ox domain, and dimerized in air to yield indigoidine 11, 19. However, it is
also possible that the oxidation happens when the substrate is linked to the Tdomain 19. In this case, T-tethered L-Gln is firstly oxidized by the Ox domain, and
then cyclized and released from the enzyme by the TE domain 20.
Table 1 Strains possessing an indigoidine biosynthetic gene cluster.
Strains

Ref.

Arthrobacter atrocyaneus

18

Arthrobacter crystallopoietes

21

Arthrobacter polychromogenes

22

Corynebacterium insidiosum

23

Erwinia chrysanthemi

11 18 24 25

Phaeobacter sp.

12

Photorhabdus luminescens

16

Pseudomonas indigofera

26

6

Streptomyces lavendulae

13 17 19

Streptomyces aureofaciens

27

Streptomyces chromofuscus

28

1.2 Objectives
To be used in the industry, efficient production of the indigoidine blue dye
is necessary 29. In our previous study, a putative indigoidine synthetase gene (ScindC) was cloned from Streptomyces chromofuscus ATCC 49982 28.
Heterologous expression of Sc-indC in E. coli achieved indigoidine production of
20 g/L under optimized conditions. Reportedly, fed-batch fermentation of an
engineered fungi Rhodosporidium toruloides with bpsA also produced indigoidine
reaching titers of 86.3 7.4 g/L30. Exploring the mechanisms of indigoidine
synthesis would potentially open new doors to further improve the production or
create new indigoidine derivatives. Though arduous studies have been done on
NRPSs, the synthetic mechanism of indigoidine through such a simple monomodule NRPS is still unknown. To better understand the enzymatic mechanism
of NRPSs, this study was aimed to explore the biosynthetic process of indigoidine
by working on bpsA and Sc-indC.
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CHAPTER II MATERIALS AND METHODS
2.1 General Methods
Products were analyzed and purified on an Agilent (Santa Clara, CA,
USA) 1200 HPLC instrument equipped with a UV detector and a C18-reversed
phase HPLC column (4.6 × 250 mm, 50 μm KANTO Reagents, Japan). ESI-MS
spectra were obtained on an Agilent 6130 quadrupole LC-MS. NMR spectra were
recorded on a Bruker (Billerica, MA, USA) NMR instrument (500 MHz for 1H
NMR). The chemical shift (δ) values were given in parts per million (ppm). The
coupling constants (J values) were reported in Hertz (Hz).
2.2 Strains, Media and Culture Conditions
Streptomyces chromofuscus ATCC 49982 and Streptomyces lavendulae
ATCC 11924 were obtained from the American Type Culture Collection (ATCC).
They were grown at 30℃ in YEME medium 1 for the extraction of genomic
DNA. E. coli XL1-Blue was used for routine cloning and amplification; E. coli
BAP1 was used for protein expression. They were grown at 37°C on Luria–
Bertani (LB) agar plates or in liquid LB medium supplemented with appropriate
antibiotics (ampicillin, 50 μg/ml; kanamycin, 50 μg/ml; streptomycin, 50 μg/ml).
When OD600 value reached 0.4~0.6, the expression host E. coli BAP1 was
induced with 200 μM of isopropyl-1-thio--D-galactopyranoside (IPTG), and
incubated at 18°C or 28°C for enzyme expression.
2.3 Gene Manipulation and Plasmid Construction
Restriction enzymes, Phusion® High-Fidelity DNA polymerase, and T4
DNA ligase were purchased from New England Biolabs (Ipswich, MA, USA).
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The GeneJETTM Plasmid Miniprep Kit and GeneJETTM PCR Purification Kit were
purchased from Fermentas (Glen Burnie, MD, USA) for plasmids extraction and
gel purification. The CloneJET™ PCR Cloning Kit was purchased from
Fermentas (Glen Burnie, MD, USA) for DNA cloning and sequencing. The
pET28a and pCDFDuet-1 vectors were purchased from Novagen (Madison, WI,
USA) for protein expression in E. coli BAP1. The Sc-indC gene 2 and bpsA gene 3
were cloned from the genome of Streptomyces chromofuscus ATCC 49982 and S.
lavendulae ATCC 11924, respectively. The primers for PCR amplification were
shown in Table 2. The PCR products were gel purified and ligated into the
pJET1.2 cloning vector to yield pFC12 and pFC13, respectively (Table 3). The
genes were confirmed by digestion check and DNA sequencing.
The genes were excised from pFC12 and pFC13 via NdeI/HindIII, and
ligated to pET28a between the same sites to form pFC15 and pFC14 (Table 3).
The Sc-indC and bpsA related gene fragments were amplified by PCR from
pFC15 and pFC14 using corresponding primers (Table 2). Similarly, those genes
were gel purified and ligated into the pJET1.2 for amplification (Table 3). After
confirmed by digestion check and DNA sequencing, they were excised from
pJET1.2-derived plasmids, and ligated to pET28a or pCDFDuet-1 (Table 3). The
Sc-indC-A-Ox, bpsA-TE, and bpsA-Ox genes were amplified by PCR and purified
with the PCR purification Kit. After digesting with appropriate sites, they were
directly ligated to pET28a to yield pFC147, pFC146, and pFC148, respectively.
The primers were designed based on the Sc-indC and bpsA sequences and
synthesized by Invitrogen (Carlsbad, CA, USA).
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Table 2 Primers used for PCR amplification in this study.
Primer
Sc-indC-PacI-NdeI-5
Sc-indC-HindIII-NheI-3
Sc-indC-PacI-NdeI-5
Sc-indC-T-XhoI-HindIII-stop-3
Sc-indC-PacI-NdeI-5
Sc-indC-Ox-long-XhoI-stop-3
Sc-indC-TE-NdeI-5
Sc-indC-HindIII-NheI-3
Sc-indC-T-NdeI-5
Sc-indC-HindIII-NheI-3
Sc-indC-Ox-NdeI-5
Sc-indC-Ox-XhoI-3
Sc-indC-Ox-long-NdeI-5
Sc-indC-Ox-long-XhoI-stop-3
Sc-indC-TE-NdeI-5
Sc-indC-TE-XhoI-stop-3
BpsA-NdeI-5
11924-BpsA-HindIII-3
BpsA-Ox-long-NdeI-5
BpsA-Ox-long-XhoI-stop-3
BpsA-Ox-NdeI-5
BpsA-Ox-XhoI-stop-3
BpsA-TE-NdeI-5
11924- BpsA-HindIII-3

Sequence (5′-3′)
TTAATTAACATATGAGCGTAGAGACCATCCCCTGCT
AAGCTTGCTAGCTTTCAGTAGTTGGGCGTCTTGC
TTAATTAACATATGAGCGTAGAGACCATCCCCTGCT
AACTCGAGAAGCTTTCAGCCCCTGCCCTCGGGCTGGAG
TTAATTAACATATGAGCGTAGAGACCATCCCCTGCT
AACTCGAGTCAGACCAGGCTGATACCGAA
AACATATGGAGGCCACGTCACCCCGGC
AAGCTTGCTAGCTTTCAGTAGTTGGGCGTCTTGC
AACATATGCAGACCACTCAGGAAGCCCAACTGACC
AAGCTTGCTAGCTTTCAGTAGTTGGGCGTCTTGC
AACATATGCGCGACGAACTCGGTACGAT
AACTCGAGGAAGCTGCCCAGGTAGTGGT
AACATATGCTGGCCCACCCCGGCTGCC
AACTCGAGTCAGACCAGGCTGATACCGAA
AACATATGGAGGCCACGTCACCCCGGC
AACTCGAGTCACACTCCGACCTCCTGGACC
AACATATGACTCTTCAGGAGACCAGCGTGCTC
AAAAGCTTCTCGCCGAGCAGGTAGCGGATGTG
AACATATGAAGGCGCAGCTGTCCAACCCGG
AACTCGAGTCAGTACTTCAGCCACTCCTCC
AACATATGTACTCGCGCAAGGCGGCCGACC
AACTCGAGTCAGTAGTAGTCCTCGTCGGCG
AACATATGCTGGAGCGCGAGGTCGCCCAG
AAAAGCTTCTCGCCGAGCAGGTAGCGGATGTG

15

Gene size
4,134 bp

Product
Sc-indC

3,084 bp

Sc-indC-A-Ox-T

2370 bp

Sc-indC-A-Ox

1110 bp

Sc-indC-TE

1374 bp

Sc-indC-T-TE

435 bp

Sc-indC-Ox

873 bp

Sc-indC-long Ox

888 bp

Sc-indC-TE-2

3849 bp

BpsA

900 bp

BpsA-long Ox

450 bp

BpsA-Ox

828 bp

BpsA-TE

BpsA-TE-NcoI-5
AACCATGGTGCTGGAGCGCGAGGTCGCCCAG
11924- BpsA-HindIII-3
AAAAGCTTCTCGCCGAGCAGGTAGCGGATGTG
BpsA-T-BamHI-NdeI-5
AAGGATTCCATATGGCCGCCTCCGACCAGGTCAAC
BpsA-T-HindIII-EcoRI-3
TTGAATTCAAGCTTAGGCCTTGCCGGTCTCCGCGTGCAG
BpsA-NdeI-5
AACATATGACTCTTCAGGAGACCAGCGTGCTC
BpsA-T-HindIII-EcoRI-3
TTGAATTCAAGCTTAGGCCTTGCCGGTCTCCGCGTGCAG
BpsA-T-BamHI-NdeI-5
AAGGATTCCATATGGCCGCCTCCGACCAGGTCAAC
11924-BpsA-HindIII-3
AAAAGCTTCTCGCCGAGCAGGTAGCGGATGTG
BpsA-NdeI-5
AACATATGACTCTTCAGGAGACCAGCGTGCTC
BpsA-A-Ox-HindIII-3
ATAAGCTTCTCCGTCTCCGTGCGCGGGGCGACGAAG
Note: the enzyme digestion sites are underlined; “bp” refers to “base pair”.
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828 bp

BpsA-TE-2

327 bp

BpsA-T

3087 bp

BpsA-A-Ox-T

1089 bp

BpsA-T-TE

2832 bp

BpsA-A-Ox

Table 3 Plasmids constructed in this study.
Plasmid
pFC12
pFC13
pFC14
pFC15
pFC135
pFC136
pFC137
pFC138
pFC139
pFC140
pFC146
pFC147
pFC148
pYC41
pYC42
pYC43
pYC44
pYC45
pYC46
pYC47
pYC48
pYC49
pYC50
pYC51
pYC52
pYC53
pYC54
pYC55
pYC56
pYC57
pYC58
pYC59

Description
Sc-indC in pJET1.2
BpsA in pJET1.2
BpsA in pET28a
Sc-indC in pET28a
Sc-indC-Ox in pJET1.2
Sc-indC-Ox in pET28a
Sc-indC-TE in pJET1.2
Sc-indC-long Ox in pJET1.2
Sc-indC-TE in pET28a
Sc-indC-long Ox in pET28a
BpsA-TE in pET28a
Sc-indC-A-Ox in pET28a
BpsA-Ox in pET28a
BpsA-A-Ox in pJET1.2
BpsA-A-Ox in pET28a
BpsA-A-Ox-T in pJET1.2
BpsA-T in pJET1.2
BpsA-T-TE in pJET1.2
BpsA-T-TE in pCDFDuet-1
BpsA-TE in pCDFDuet-1
BpsA-A-Ox-T in pET28a
BpsA-T in pET28a
Sc-indC-A-Ox in pJET1.2
Sc-indC-T-TE in pJET1.2
Sc-indC-TE in pJET1.2
Sc-indC-A-Ox-T in pJET1.2
BpsA-TE-2 in pJET1.2
Sc-indC-A-Ox in pCDFDuet-1
Sc-indC-T-TE in pET28a
Sc-indC-TE-2 in pET28a
Sc-indC-A-Ox-T in pCDFDuet-1
BpsA-TE-2 in pCDFDuet-1

Ligation sites
NdeI/HindIII
NdeI/HindIII
NdeI/XhoI
NdeI/XhoI
NdeI/XhoI
NdeI/XhoI
NdeI/XhoI
NdeI/HindIII
NdeI/HindIII
NdeI/XhoI
NdeI/XhoI
NdeI/HindIII
NdeI/HindIII
NdeI/XhoI
NdeI/HindIII
NdeI/HindIII
NdeI/XhoI
NcoI/HindIII

Table 4 E. coli BAP1 transformants and screening antibiotics.
Transformants
1
2
3
4
5

Description
pFC14
pFC15
pFC136
pFC139
pFC140

Antibiotics
K
K
K
K
K
17

Protein/domains
BpsA
Sc-IndC
Sc-IndC-Ox
Sc-IndC-TE
Sc-IndC-long Ox

6
pFC146
K
BpsA-TE
7
pFC147
K
IndC-A-Ox
8
pFC148
K
BpsA-Ox
9
pYC42
K
BpsA-A-Ox
10
pYC46
S
BpsA-T-TE
11
pYC42/pYC46 K + S
BpsA-A-Ox/BpsA-T-TE
12
pYC47/pYC48 K + S
BpsA-A-Ox-T/BpsA-TE
13
pYC46/pYC48 K + S
BpsA-A-Ox-T/BpsA-T-TE
14
pYC48
K
BpsA-A-Ox-T
15
pYC49
K
BpsA-T
16
pYC48/pYC59 K + S
BpsA-A-Ox/BpsA-T
17
pYC55/pYC56 K + S
Sc-IndC-A-Ox/ Sc-IndC-T-TE
18
pYC57/pYC58 K + S
Sc-IndC-TE/ Sc-IndC-A-Ox-T
Note: “K” refers to kanamycin, “S” refers to streptomyces.
2.4 Gene Expression in E. coli BAP1 and Protein Purification
The pET28a and pCDFDuet-1-derived plasmids were expressed or coexpressed in E. coli BAP1 (Table 4). Correct transformants 1-18 were selected on
LB agar supplemented with corresponding antibiotics, and then grown in 50 ml of
LB broth supplemented with appropriate antibiotics at 37℃ and 250 rpm. When
the OD600 reached 0.4~0.6, IPTG was added at a final concentration of 200 μM to
induce the expression at 18℃ or 28℃ for 18-20 hours.
2.5 SDS-PAGE Analysis of Protein Expression and Purification
After expression, the cells were collected by centrifugation at 2,100×g for
10 minutes and resuspended in 5 ml of lysis buffer (20 mM Tris–HCl, 500 mM
NaCl, pH 7.9). After 5 minutes of ultrasonication (18 W, 45-second interval in
every 15-second), the resulting lysates were centrifuged at 21,000×g for 30
minutes. The isoluble proteins were dissolved in 8 M urea. Both soluble and
insoluble fractions (designated as sample S and sample IS) were analyzed by 1012 % SDS-PAGE.
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The soluble proteins were mixed with 200 μl of HisPur Ni-NTA Resin (Thermo
Fisher Scientific, Waltham, MA, USA), and incubated at 4℃ for 5 hours, and
then the mixture was loaded to the gravity-flow column to drain out, which was
how we got sample F. The packed resin was washed with four resin-bed volumes
of buffer A (50 mM Tris–HCl, 2 mM EDTA, pH 7.9) (sample A), 25 mM
imidazole-buffer A (sample 25), and 50 mM imidazole-buffer A (sample 50) in a
series, and the His-tagged proteins were eluted from the resin with two resin-bed
volumes of 250 mM imidazole-buffer A (sample 250). Each flow-through was
collected in a separate tube and subjected to SDS-PAGE to monitor the protein
elution and purity. The target protein elution was condensed with centrifugal filter
units (Sigma-Aldrich, St. Louis, MO, USA) at 2,100×g, and stored in the PB
reaction buffer (50 mM Na2HPO4, 50 mM KH2PO4) with 50% v/v glycerol at 20℃.
2.6 Chemical Synthesis of Aminoacyl-N-acetylcysteamine Thioesters: Lglutamine-SNAC
We modified a previous method 4 and chemically synthesized Lglutamine-SNAC (L-Gln-SNAC) (see Figure 5) as a mimicking substrate for in
vitro enzymatic assays. In step 2, the synthesized aminoacyl-SNAC and Bocaminoacyl-SNAC were purified by HPLC with CH3CN/H2O/formic acid 5:95:0.1,
and L-Gln-SNAC was purified by HPLC with CH3CN/H2O/formic acid 2:98:0.1.
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Figure 5 Protocol for chemical synthesis of L-glutamine-SNAC.

Figure 6 Schematic diagram for chemical synthesis of L-glutamine-SNAC.
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2.7 Identification of the Substrate and Intermediates
Characterization of L-Gln: 1H NMR (D2O):  3.77 (1H, dd, J = 4.20, 7.99
Hz), 2.46 (2H, m), 2.14 (2H, dd, J = 6.98, 13.94 Hz).
Characterization of L-Gln-SNAC: 1H NMR (D2O):  4.36 (1H, dd, J =
5.45, 13.44 Hz), 2.87 (2H, m), 2.43 (1H, m), 2.22 (1H, m); ESI-MS: [M+H]+ m/z
248.
Characterization of 3-aminopiperidine-2,6-dione (pyro-Gln): 1H NMR
(D2O):  4.39 (1H, t, J = 6.28 Hz), 3.45 (2H, m), 3.27 (1H, dt, J = 6.35, 13.02
Hz), 3.16 (1H, m), 2.52 (2H, m), 2.31 (1H, td, J = 7.09, 14.13 Hz), 2.21 (1H, td, J
= 7.20, 14.70 Hz), 1.98 (3H, s); ESI-MS: [M+H]+ m/z 129.
2.8 In vitro Enzymatic Reactions
The in vitro enzymatic reaction system was prepared according to Table 5,
and reacted at 28℃ for 2 hours. The substrate and intermediates referred to the
native substrate L-Gln (Sigma-Aldrich, St. Louis, MO, USA), chemically
synthesized mimicking substrate L-Gln-SNAC, and 3-aminopiperidine-2,6-dione
(pyro-Gln) (Sigma-Aldrich, St. Louis, MO, USA).
Table 5 Protocol for in vitro enzyme assay.
Ingredients

Final concentration

ATP/MgCl2/PB buffer

1 mM/1mM

Substrate/intermediates 1 mM
Enzyme

1–10 μΜ

PB Buffer, pH7.5

50 mM
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2.9 Analysis of Products
The in vivo production of indigodine was checked visually or by
GENESYS 20 ultraviolet spectrophotometer (Thermo Fisher Scientific, Waltham,
MA, USA).
The enzymatic reactions were quenched by adding equal volume of
methanol. The products were centrifuged at 21,000×g for 20 minutes, and the
supernatants or precipitates (dissolved with DMSO) were injected into the HPLC
with a gradient mobile phase of CH3CN/H2O (0.1% formic acid) (0:100 – 90:10,
20 minutes) at 1 ml/minute.
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CHAPTER III RESULTS
3.1 PCR for Gene Fragments
Plasmid pFC14 and pFC15 were used as template for PCR amplification,
and gene fragments bpsA-A-Ox (2832 bp), bpsA-A-Ox-T (3087 bp), bpsA-T (327
bp), bpsA-T-TE (1089 bp), bpsA-TE (828 bp), Sc-indC-A-Ox (2370 bp), Sc-indCA-Ox-T (3084 bp), Sc-indC-T-TE (1374 bp), Sc-indC-TE (1110 bp) were obtained
using corresponding primers listed in Table 2.

Figure 7 PCR result for dissected bpsA gene fragments.

Figure 8 PCR result for dissected Sc-indC gene fragments.
3.2 Protein Expression and Purification
Expression plasmids pFC14, 15, 136, 139, 140, 146-148, pYC42, 46-49,
55-59 (Table 3) were constructed, and were transferred into E. coli BAP1 to get
transformants 1-18 (Table 4) for protein expression in LB broth. Below are the
SDS-PAGE analysis for protein expression and purification.
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Expression of pFC14 (BpsA) (18℃).

Figure 9 SDS-PAGE for the expression of pFC14 (BpsA).
Note: S-soluble, IS-insoluble, M-protein marker, F-flow through, A-buffer A
elution, 5-5 mM imidazole/buffer A elution, 10-10 mM imidazole/buffer A
elution, 250-250 mM imidazole/buffer A elution.
Expression (18℃) and purification of pYC49 (BpsA-T).

Figure 10 SDS-PAGE for the expression of pYC49 (BpsA-T).
Expression of pFC136 (Sc-IndC-Ox).
The plasmid pFC136 was transferred into various E. coli strains including
E. coli BAP1, E. coli BL21(DE3), E. coli BL21(DE3)-pLysS, E. coli BL21(DE3)RIL, and expressed at different temperatures (18 or 28℃). However, all showed
that the target proteins were in the insoluble parts.
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Figure 11 SDS-PAGE for the expression of pFC136 (Sc-IndC-Ox).
Expression (28℃) and purification of pFC139 ((Sc-IndC-TE).

Figure 12 SDS-PAGE for the expression of pFC139 ((Sc-IndC-TE).
Expression (28℃) and purification of pFC146 (BpsA-TE).

Figure 13 SDS-PAGE for the expression of pFC146 (BpsA-TE).
Expression (18℃) and purification of pFC147 (Sc-IndC-A-Ox).
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Figure 14 SDS-PAGE for the expression of pFC147 (Sc-IndC-A-Ox).
Expression (28℃) and purification of pFC148 (BpsA-Ox).

Figure 15 SDS-PAGE for the expression of pFC148 (BpsA-Ox).
Table 6 Expression/purification of proteins and dissected domains.
Plasmid Protein/Domain Expression/Purification
pFC14

BpsA

Purified

pFC15

Sc-IndC

Purified

pFC136 Sc-IndC-Ox

Expressed in insoluble

pFC139 Sc-IndC-TE

Purified

pFC146 BpsA-TE

Purified

pFC147 Sc-IndC-A-Ox

Purified

pFC148 BpsA-Ox

Purified

pYC49

Purified

BpsA-T
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3.3 Chemical Synthesis of L-Glutamine-SNAC
The synthesis of SNAC provided 400 mg N-acetylcysteamine mixture,
which was confirmed by LC-MS.
The product mixture of Boc-aminoacyl-SNAC was subjected to LC-MS to
locate the target compound.

Figure 16 HPLC analysis of the synthesized samples of N-acetylcysteamine and
Boc-aminoacyl-SNAC.

Figure 17 MS spectra of N-acetylcysteamine and Boc-aminoacyl-SNAC.
Boc-aminoacyl-SNAC was then purified with HPLC to afford the single
compound for the next deprotecion reaction.
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Figure 18 A typical HPLC trace of Boc-aminoacyl-SNAC purification.
After deprotection, the mixture was analyzed by LC-MS to locate the
target compound L-Gln-SNAC, which was finally purified with HPLC to yield 5
mg of white powder.

Figure 19 LC-MS analysis of aminoacyl-SNAC in the de-protected mixture.
HPLC trace (top), UV spectrum (bottom left), MS spectrum (bottom right).

Figure 20 A representative HPLC trace of L-glutamine-SNAC purification.
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Figure 21 Purity check of L-glutamine-SNAC after purification.
3.4 Characterization of the Substrate and Intermediates

Figure 22 Chemical structures of the substrate and intermediates.
L-Gln, L-Gln-SNAC, and pyro-Gln were characterized by 1H NMR (D2O).

Table 7 1H NMR data (500 MHz) for the substrate and intermediates (in D2O).
Position

L-Gln

L-Gln-SNAC

Pyro-Gln

2 or 3

3.77 (1H, dd, 8.0,

4.36 (1H, dd,

4.39 (1H, t, 6.3)

4.2)

13.4, 5.5)

2.14 (2H, m)

2.43 (1H, m),

2 or 3

2.52 (2H, m)

2.22 (1H, m)
4

2.46 (2H, m)

2.87 (2H, m)

2.31 (1H, td, 14.2, 7.1),
2.21 (1H, td, 14.2, 7.2)

1′ or 2′

3.27 (1H, td, 13.0, 6.4),
3.16 (1H, m)

1′ or 2′

3.45 (2H, m)

2′′

1.98 (3H, s)
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Characterization of L-glutamine.

Figure 23 HPLC analysis of L-glutamine.
Characterization of L-glutamine-SNAC.

Figure 24 LC-MS analysis of purified L-glutamine-SNAC.
HPLC trace (top), UV spectrum (bottom left), MS spectrum (bottom right).
Characterization of 3-aminopiperidine-2,6-dione.
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Figure 25 LC-MS analysis of 3-aminopiperidine-2,6-dione hydrochloride.
HPLC trace (top), UV spectrum (bottom left), MS spectrum (bottom right).
3.5 In vitro Enzyme Activity and Heterologous Co-expression

Figure 26 Proposed biosynthetic process of indigoidine.
Enzymatic activity of Sc-IndC and BpsA with L-glutamine, and the effect of
reaction temperature (18℃ or 28℃).
It showed that BpsA had higher in vitro activity than Sc-IndC, and the
effect of the two temperatures on the productivity was not significant (Figure 27).
Hence the following reactions were conducted at 28℃.
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Figure 27 Enzymatic activity of Sc-IndC and BpsA with L-glutamine.
From left to right: Sc-IndC, 18℃; BpsA, 18℃; Sc-IndC, 28℃; BpsA, 28℃.
Enzymatic activity of BpsA with different amounts of L-glutamine and ATP.
The substrate L-Gln was tested at 1, 4, and 8 mM. However, no significant
difference was observed, so 1 mM substrate was applied to the following
enzymatic reaction system.
Similarly, ATP was tested in the reactions at 0.5, 1, 2, and 4 mM,
respectively, and 1 mM ATP worked the best in this system. Higher
concentrations of ATP might have inhibited the reaction.

Figure 28 Enzymatic activity of BpsA with different amounts of L-glutamine and
ATP.
From left to right: 0.5 mM ATP/1 mM L-Gln; 0.5 mM ATP/4 mM L-Gln; 0.5 mM
ATP/8 mM L-Gln; 1 mM ATP/1 mM L-Gln; 1 mM ATP/4 mM L-Gln; 1 mM
ATP/8 mM L-Gln.
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Figure 29 Enzymatic activity of Sc-IndC and BpsA with different amounts of
ATP.
From left to right: BpsA/1 mM ATP; BpsA/2 mM ATP; BpsA/4 mM ATP; ScIndC/1 mM ATP; Sc-IndC/2 mM ATP; Sc-IndC/4 mM ATP.
Enzymatic activity of BpsA with L-glutamine, 3-aminopiperidine-2,6-dione
hydrochloride, and L-glutamine-SNAC.
When BpsA was reacted with L-glutamine, 3-aminopiperidine-2,6-dione
hydrochloride, and L-glutamine-SNAC, all the reactions turned blue. HPLC and
UV analysis indicated that indigoidine was synthesized, which was further
confirmed by MS analysis. These indicated that BpsA not only takes the substrate
L-Gln, but also converts the intermediate pyro-Gln and the mimicking

intermediate L-Gln-SNAC to the blue dye.
Based on the color intensity, we found that the blue color of the L-Gln
group was deeper than that of pyro-Gln and L-Gln-SNAC. Thus, we supposed that
though BpsA could convert all these three compounds to indigoidine, it had
higher activity on the native substrate, L-Gln.
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Figure 30 HPLC analysis of the enzymatic reactions of BpsA with L-glutamine, 3aminopiperidine-2,6-dione hydrochloride, or L-glutamine-SNAC.

Figure 31 MS spectrum of indigoidine synthesized in the enzymatic reactions.
Interestingly, in the reaction buffer of BpsA with L-Gln-SNAC, except for
the production of the blue pigment, the supernatant turned yellowish (as shown in
Figure 33). LC-MS analysis showed that there was an extra peak of MW 358
produced (Figure 34 and Figure 35). Further work needs to be done to find the
structure of this compound.
Without

ATP,

neither

Sc-IndC

substrate/intermediates to indigoidine.
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nor

BpsA

can

convert

these

Table 8 Enzymatic reaction of BpsA with L-glutamine, 3-aminopiperidine-2,6dione hydrochloride, and L-glutamine-SNAC.
Ingredients

Concentration

ATP

1 mM

MgCl2

1 mM

Substrate

1 mM

1

1B

1

2

2B

0 mM

L-Gln

L-Gln

L-Gln

0 mM

pyro-

pyro-Gln

Gln
BpsA

15 ul

PB, pH7.5

50 mM

Result

ATP

1 mM

MgCl2

1 mM

Substrate

1 mM

BpsA

15 ul

PB, pH7.5

50 mM

Result

2

Inactive

pyroGln

Inactive

****

/

/

*

/

/

/

/

/

/

/

/

3

3B

3

4

4B

4

0 mM

0 mM

L-Gln-

L-Gln-

L-Gln-

L-Gln-

L-Gln-

L-Gln-

SNAC

SNAC

SNAC

SNAC

SNAC

SNAC

Inactive

Inactive

**

/

/

***

/

/



/

/



/

/

Note:
“*” Represents there was blue precipitate produced, and the number of “*” indicates
the color intensity.
“” Represents the reaction buffer turned yellow, and the number of “” indicates
the color intensity.
“1” Indicates there was no ATP added to the reaction buffer.

35

“/” Indicates no apparent color change was observed.
“Inactive” The BpsA was inactivated by heating at 98℃ for five minutes.

Figure 32 In vitro enzymatic reaction of BpsA with L-glutamine, 3aminopiperidine-2,6-dione hydrochloride, and L-glutamine-SNAC.
Top: Picture for all the reaction groups. Bottom left: picture for Group 1-4.
Bottom right: picture for Group 1-4 after centrifuging at 21,000×g.
Enzymatic assay of dissected fragments of the indigoidine synthetase.
With or without ATP or FAD, the TE, Ox, and TE/ Ox domains didn’t work
on the precursors.
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Table 9 In vitro enzymatic assay result for the domains′ functional
characterization.
Enzyme assay

Enzymes

Color change LC-MS

pFC139, L-Gln

Sc-indC-TE

/

/

pFC139, L-Gln-SNAC

Sc-indC-TE

/

/

pFC139, pyro-Gln

Sc-indC-TE

/

/

pFC140, L-Gln

Sc-IndC-LOx

/

/

pFC140, pyro-Gln

Sc-IndC-LOx

/

/

pFC146, L-Gln

BpsA-TE

/

/

pFC146, L-Gln-SNAC

BpsA-TE

/

/

pFC146, pyro-Gln

BpsA-TE

/

/

pFC146/pFC147, L-Gln

BpsA-TE, Sc-IndC-A-Ox /

/

pFC146/pFC147, pyro-Gln BpsA-TE, Sc-IndC-A-Ox /

/

pFC147, L-Gln

Sc-IndC-A-Ox

/

/

pFC147, pyro-Gln

Sc-IndC-A-Ox

/

/

pFC148, L-Gln

BpsA-Ox

/

/

pFC148, L-Gln-SNAC

BpsA-Ox

/

/

pFC148, pyro-Gln

BpsA-Ox

/

/

Note: “/” indicates no possible intermediates or final products were detected.
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Figure 33 In vitro reactions of BpsA or dissected fragments of BpsA/Sc-IndC
with L-glutamine-SNAC.
From left to right: BpsA/L-Gln; BpsA/L-Gln-SNAC; BpsA-TE/L-Gln-SNAC; ScIndC-A-Ox/L-Gln-SNAC, blank control (without any enzyme).

Figure 34 LC-MS analysis of the reaction products in the supernatant.
Possible molecule weights of the peaks were labeled based on the MS analysis.
From top to bottom: BpsA with L-Gln, pyro-Gln, and L-Gln-SNAC.
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Figure 35 UV and MS spectra for the enzymatic reaction product of molecular
weight 358.
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Figure 36 Time course analysis of the in vitro reaction of BpsA with L-glutamine.
The time course analysis of the in vitro reaction of BpsA with L-Gln showed
that the indigoidine production increased with the reaction time.
LC-MS analysis (not shown in this paper) for the supernatant taken at t =
15 minute, 30 minute, 1 hour, and 2 hours showed similar HPLC traces, and no MS
signals of expected intermediates pyro-Gln (MW128), oxidized pyro-Gln (126),
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and indigoidine (248) were tracked, likely due to the extremely low amounts.
Signals of ATP and its derivatives were found (ATP, ADP, and AMP).
Heterologous co-expression.
Heterologous co-expression of transformants 11-13, 16-18 (Table 4) in LB
at 18℃ or 28℃ didn’t get the blue dye, while the positive control E. coli
BAP1/pFC15 turned deep blue. HPLC analysis of these co-expression experiments
also didn’t detect any indigoidine in the broth and cells.
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CHAPTER IX DISCUSSION AND CONCLUSIONS
We live in a world full of pigments. Chemical synthesis has been a
predominant source of pigments in industry, which not only brings serious
environmental pollution, but also raises health concerns, especially from the
applications in food, medical, and cosmetic industries. An alternative to
traditional chemical method is biosynthesis, which is environmentally
advantageous with regard to sustainability and less chemical hazards.
Biosynthetic natural products have better safety profiles than those chemically
synthesized for food and pharmaceutical applications. Hence natural colorants and
dyes have been of great interest with the increasing attention to environment
protection and human health.
Indigoidine is a bacteria-derived natural blue dye. It has the advantages of
antioxidant and anti-microbial activities. Technically, the responsible biosynthetic
genes are more compatible to be recombinated in engineering host models for
large-scale production. Previously, we expressed Sc-indC in E. coli BAP1 and
reached a production of ~20 g/L using L-glutamine in a batch fermentation. In
another case, an engineered yeast with bpsA produced indigoidine reaching titers
of ~86 g/L using glucose in a fed-batch fermentation. These indicate that
indigoidine has great potential to be produced in mass production by biosynthetic
approach. To further improve the production, this study dedicated to reveal the
biosynthetic process of indigoidine by BpsA and Sc-IndC originated from two
different strains.
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In this study, both BpsA and Sc-IndC were functionally expressed in E.
coli BAP1, which confirmed that their catalytic activity can reconstituted in vitro.
This provided a great platform for the following study on the catalytic domains in
these modular NRPSs.
By dissecting the indigoidine synthetic genes Sc-indC and bpsA, we
established a library of biosynthetic bricks with four biosynthetic domains,
including A, Ox, T, and TE domain. The dissected domains were co-expressed in
E. coli BAP1 in different combinations, or expressed individually and purified for
in vitro enzymatic assay to test their function in the biosynthesis of indigoidine.
The intermediate L-Gln-SNAC, an aminoacyl-N-acetylcysteamine
thioester (aminoacyl-SNAC) was chemically synthesized and characterized. In
vitro enzymatic assay showed that the intact BpsA enzyme could take it as a
precursor to synthesize indigoidine.
BpsA, as an intact enzyme, with the presence of ATP, worked on the
native substrate, L-Gln, the intermediate, pyro-Gln, and the mimicking
intermediate, L-Gln-SNAC, to produce indigoidine. However, no predicted
intermediates, according to the proposed biosynthetic pathway from the literature,
were detected by LC-MS during the reaction process. Furthermore, in the reaction
of BpsA with L-Gln-SNAC, there was a molecule of MW 358 produced, which
might contribute to the emerged yellow color in the reaction buffer and might be a
possible intermediate produced in the biosynthetic process of indigoidine.
When the indigoidine synthetases were split into domains and worked
individually on the native substrate L-Gln or the intermediates, neither putative
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intermediates nor the final product indigoidine was detected. Even when various
domains were co-existed in vitro, no apparent activity was observed. For the coexpression of the combinations of dissected domains A-Ox/T-TE, A-Ox-T/TE, no
blue dye was produced, which indicates no apparent activity of the dissected
domains neither. It is possible that the in vitro reaction system or fermentation
condition not benefit the enzymatic activities of the dissected domains. But we
cannot exclude the possibility that the truncated and dissected enzymes might
have less activity or maybe even inactive. In this case, the reaction methods need
to be further optimized. Alternatively, gene deficit or site-directed mutagenesis,
rather than dissection and co-expression methods, might be applied to study the
biosynthetic mechanism of the indigoidine biosynthetic process.
This study provided important platforms and technical basis for further
study on the biosynthetic mechanism of indigoidine. Further work needs to be
done to reveal the biosynthetic process and improve the production of indigoidine.
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APPENDICES

Figure 37 1H NMR spectrum of L-glutamine (in D2O).

Figure 38 1H NMR spectrum of L-glutamine-SNAC (in D2O).

44

Figure 39 1H NMR spectrum of 3-aminopiperidine-2,6-dione (in D2O).

Figure 40 HPLC trace and UV spectrum of indigoidine.
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